Revenue
2011
2022
2023
2025
2026
| 2026 | 2025 | 2023 | 2022 | 2021 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | N/A | $0 | N/A | N/A |
| Research & development | $2.9M | $1.1M | $433,799 | $377,387 | N/A | N/A | N/A | N/A |
| Operating expenses | $24.6M | $8.6M | $8.6M | $3.3M | $64,517 | N/A | N/A | N/A |
| Operating income | −$24.6M | −$8.6M | −$8.6M | −$3.3M | N/A | N/A | N/A | N/A |
| EBITDA | −$23.1M | −$7.2M | −$8.2M | −$3.2M | N/A | N/A | N/A | N/A |
| Net income | −$23.4M | −$7.6M | −$8.3M | −$3.2M | −$64,517 | $2.4M | −$1.4M | −$53,182 |
| Basic EPSper basic share | -CA$2.10 | -CA$1.00 | -CA$0.15 | -CA$0.13 | -CA$0.11 | N/A | N/A | N/A |
| Diluted EPSper diluted share | -CA$2.10 | -CA$1.00 | -CA$0.15 | -CA$0.13 | N/A | N/A | N/A | N/A |
Reported shareholders